Answers are grounded in this paper and cite their sources.
Context: Some studies have reported that the phospholipase domain-containing protein 3 (PNPLA3) rs738409 GG homozygous genotype is associated with increased risk of liver disease severity in patients with biopsy-proven nonalcoholic fatty liver disease (NAFLD). Given the increasing global prevalence of NAFLD and the lack of definitive treatment for non-alcoholic steatohepatitis (NASH) or a first-line therapy for NAFLD, many researchers are seeking a cure for NASH in individuals with NAFLD who have the rs738409 GG homozygous genotype. Objectives: We conducted a systematic review and meta-analysis to assess the proportion of PNPLA3 rs738409 GG homozygous individuals in different populations and its impact on fibrosis progression in biopsy-proven NAFLD patients, to support data basis for Precision Gene Therapy of NAFLD. Methods: PubMed, Cochrane Library, and Embase database were searched for case-control studies from inception to July 3, 2024. The following keywords were used: Fatty liver, PNPLA3, and rs738409 gene or variants or polymorphism or alleles. A meta-analysis and systematic review were conducted utilizing the articles retrieved. Results: A total of 13 eligible studies and 3823 people were included in this study. The pooled PNPLA3 rs738409 GG homozygous proportion of NAFLD was estimated to be 30% (95% CI: 0.22 - 0.37) in adults, 24% (95% CI: 0.15 - 0.33) in adolescents, 33% (95% CI: 0.26 - 0.39) in the Asian population, 39% (95% CI: 0.32 - 0.47) in Japanese, and 25% (95% CI: 0.22 - 0.28) in Chinese. Advanced fibrosis (≥ 2) was estimated to be 11% (95% CI: 0.07 - 0.16) in adults, 11% (95% CI: 0.06 - 0.16) in the Asian population, and 15% (95% CI: 0.07 - 0.23) in Japanese. Two articles from the Chinese population showed that advanced fibrosis (≥ 2) was estimated to be 5.9% and 4.8%. Our results showed that the incidence of GG homozygous in patients with advanced fibrosis (≥ 2) had a 1.27-fold and 1.24-fold greater proportion compared with low-level fibrosis (< 2) in adult and Asian populations, respectively. Conclusions: The rs738409 GG homozygous proportion in biopsy-proven NAFLD varies due to geographic and population heterogeneity. Our results showed that rs738409 GG homozygous exerts a strong influence on developing fibrosis.
No takes yet. Share an insight, caveat, or question.
Du et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: